Contact Us
- 800–CDC–INFO
- (800-232-4636)
- 888–232–6348 (TTY)
- cdcinfo@cdc.gov
Interim Antiviral Guidance for 2008-09
Although yearly vaccination with the flu vaccine is the primary strategy for preventing complications of influenza virus infections, antiviral medications with activity against influenza viruses can be effective for the prevention and treatment of influenza.
CDC has issued updated interim guidance for the use of antiviral medications during the 2008-09 influenza season. This guidance may change as more information becomes available.
CDC Health Advisory: CDC Issues Interim Recommendations for the Use of Influenza Antivirals in the Setting of Oseltamivir Resistance among Circulating Influenza A (H1N1) Viruses, 2008-09 Season
The links below provide information taken directly from the HAN as well as additional considerations regarding antiviral use during the 2008-09 influenza season.
The links below provide information on antiviral medications recommended for use in the United States during the 2008-09 influenza season.
- Table: Recommended daily dosage of influenza antiviral medications for treatment and chemoprophylaxis-United States, 2008-09
- Dosage
Guidelines for different groups, such as children, the elderly, and people with certain health conditions (includes a dosage table) - Side Effects and Adverse Reactions
Description of the rare side effects of oseltamivir and zanamivir - Pharmacokinetics
Details on the drugs' interaction with the body
Related Links
- Prevention & Control of Influenza – Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2008
- Prevention & Control of Influenza – Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2005
- Page last updated January 7, 2008
- Content Source: Coordinating Center for Infectious Diseases (CCID)
- National Center for Immunization and Respiratory Diseases (NCIRD)